| ATF4 | Activating transcription factor 4 |
| BCL-2 | B cell lymphoma 2 |
| BH3 | BCL-2 homology 3 |
| CB1/2 | Cannabinoid receptor type 1/type 2 |
| CBC | Cannabichromene |
| CBD | Cannabidiol |
| CBG | Cannabigerol |
| CBGA | Cannabigerolic acid |
| CBN | Cannabinol |
| CHOP | C/EBP homologous protein |
| CNS | Central nervous system |
| CSCs | Cancer stem cells |
| CTCL | Cutaneous T-cell lymphoma |
| ECS | Endocannabinoid system |
| ER | Endoplasmic reticulum |
| GBM | Glioblastoma multiforme |
| GPCR | G-protein coupled receptor |
| GSCs | Glioma stem cells |
| IC50 | Half maximal inhibitory concentration |
| Id1 | Inhibitor of DNA binding 1 |
| MAPK | Mitogen-activated protein kinase |
| MM | Multiple myeloma |
| MMP | Matrix metalloproteinases |
| MTORC1 | Mammalian target of rapamycin complex 1 |
| PPARs | Peroxisome proliferator-activated receptors |
| ROS | Reactive oxygen species |
| THC | Δ9–tetrahydrocannabinol |
| THCA | Δ9–tetrahydrocannabinolic acid |
| THCV | Δ9–tetrahydrocannabivarin |
| TIMP | Tissue inhibitor of metalloproteinases |
| TMZ | Temozolomide |
| TRIB3 | Tribbles homolog 3 |
| TRPA | Transient receptor potential ankyrin |
| TRPV | Transient receptor potential vanilloid |
| UC | Urothelial carcinoma |
| WHO | World Health Organization |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.